188 related articles for article (PubMed ID: 16532444)
1. Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosa.
Bhargava R; Chen B; Klimstra DS; Saltz LB; Hedvat C; Tang LH; Gerald W; Teruya-Feldstein J; Paty PB; Qin J; Shia J
Cancer; 2006 Apr; 106(8):1857-62. PubMed ID: 16532444
[TBL] [Abstract][Full Text] [Related]
2. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study.
Lee HJ; Xu X; Choe G; Chung DH; Seo JW; Lee JH; Lee CT; Jheon S; Sung SW; Chung JH
Lung Cancer; 2010 Jun; 68(3):375-82. PubMed ID: 19712993
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Dako EGFR pharmDx kit and Zymed EGFR antibody for assessment of EGFR status in colorectal adenocarcinoma.
Buckley AF; Kakar S
Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):305-9. PubMed ID: 17721276
[TBL] [Abstract][Full Text] [Related]
4. Is there an immunohistochemical technique definitively valid in epidermal growth factor receptor assessment?
Penault-Llorca F; Cayre A; Arnould L; Bibeau F; Bralet MP; Rochaix P; Savary J; Sabourin JC
Oncol Rep; 2006 Dec; 16(6):1173-9. PubMed ID: 17089034
[TBL] [Abstract][Full Text] [Related]
5. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck.
Rubin Grandis J; Melhem MF; Barnes EL; Tweardy DJ
Cancer; 1996 Sep; 78(6):1284-92. PubMed ID: 8826952
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies.
Scartozzi M; Bearzi I; Berardi R; Mandolesi A; Fabris G; Cascinu S
J Clin Oncol; 2004 Dec; 22(23):4772-8. PubMed ID: 15570078
[TBL] [Abstract][Full Text] [Related]
7. Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis.
Lee CM; Lee RJ; Hammond E; Tsodikov A; Dodson M; Zempolich K; Gaffney DK
Gynecol Oncol; 2004 Apr; 93(1):209-14. PubMed ID: 15047238
[TBL] [Abstract][Full Text] [Related]
8. EGFR-immunohistochemistry in colorectal cancer and non-small cell lung cancer: comparison of 3 commercially available EGFR-antibodies.
Buffet W; Geboes KP; Dehertogh G; Geboes K
Acta Gastroenterol Belg; 2008; 71(2):213-8. PubMed ID: 18720932
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptors in colorectal carcinoma.
Moorghen M; Ince P; Finney KJ; Watson AJ; Harris AL
Anticancer Res; 1990; 10(3):605-11. PubMed ID: 2195985
[TBL] [Abstract][Full Text] [Related]
10. Correlation of EGFR expression, gene copy number and clinicopathological status in NSCLC.
Gaber R; Watermann I; Kugler C; Reinmuth N; Huber RM; Schnabel PA; Vollmer E; Reck M; Goldmann T
Diagn Pathol; 2014 Sep; 9():165. PubMed ID: 25227424
[TBL] [Abstract][Full Text] [Related]
11. Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumors.
Melhem MF; Meisler AI; Finley GG; Bryce WH; Jones MO; Tribby II; Pipas JM; Koski RA
Cancer Res; 1992 Nov; 52(21):5853-64. PubMed ID: 1394214
[TBL] [Abstract][Full Text] [Related]
12. Implications of EGFR PharmDx kit for cetuximab eligibility.
Ensinger C; Sterlacci W
Expert Rev Mol Diagn; 2008 Mar; 8(2):141-8. PubMed ID: 18366301
[TBL] [Abstract][Full Text] [Related]
13. Expression of cripto-1 in human colorectal adenomas and carcinomas is related to the degree of dysplasia.
Saeki T; Salomon D; Gullick W; Mandai K; Yamagami K; Moriwaki S; Takashima S; Nishikawa Y; Tahara E
Int J Oncol; 1994 Sep; 5(3):445-51. PubMed ID: 21559596
[TBL] [Abstract][Full Text] [Related]
14. Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer.
Wong SF
Clin Ther; 2005 Jun; 27(6):684-94. PubMed ID: 16117976
[TBL] [Abstract][Full Text] [Related]
15. Expression of brain-type glycogen phosphorylase is a potentially novel early biomarker in the carcinogenesis of human colorectal carcinomas.
Tashima S; Shimada S; Yamaguchi K; Tsuruta J; Ogawa M
Am J Gastroenterol; 2000 Jan; 95(1):255-63. PubMed ID: 10638593
[TBL] [Abstract][Full Text] [Related]
16. Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors.
Saeki T; Stromberg K; Qi CF; Gullick WJ; Tahara E; Normanno N; Ciardiello F; Kenney N; Johnson GR; Salomon DS
Cancer Res; 1992 Jun; 52(12):3467-73. PubMed ID: 1596904
[TBL] [Abstract][Full Text] [Related]
17. Colonic mucin-carbohydrate components in colorectal tumors and their possible relationship to MUC2, p53 and DCC immunoreactivities.
Hara A; Saegusa M; Mitomi H; Kurihara M; Ishihara K; Hotta K; Okayasu I
Pathol Res Pract; 2000; 196(3):159-66. PubMed ID: 10729920
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of S100A6 (Calcyclin), a calcium-binding protein of the S100 family, in human colorectal adenocarcinomas.
Komatsu K; Andoh A; Ishiguro S; Suzuki N; Hunai H; Kobune-Fujiwara Y; Kameyama M; Miyoshi J; Akedo H; Nakamura H
Clin Cancer Res; 2000 Jan; 6(1):172-7. PubMed ID: 10656447
[TBL] [Abstract][Full Text] [Related]
19. Expression of epidermal growth factor receptor in primary colorectal adenocarcinoma predicts expression in recurrent disease.
Khalifa MA; Rowsell CH; Gladdy RA; Ko YJ; Hanna S; Smith A; Law C
Am J Clin Pathol; 2006 Feb; 125(2):229-33. PubMed ID: 16393679
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor immunohistochemistry: comparison of antibodies and cutoff points to predict benefit from gefitinib in a phase 3 placebo-controlled study in advanced nonsmall-cell lung cancer.
Hirsch FR; Dziadziuszko R; Thatcher N; Mann H; Watkins C; Parums DV; Speake G; Holloway B; Bunn PA; Franklin WA
Cancer; 2008 Mar; 112(5):1114-21. PubMed ID: 18219661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
